A practical approach to the prevention of miscarriage: Part 1 - Progesterone therapy

Clinical and Experimental Obstetrics and Gynecology

Volumn 36, Issue 4, 2009, Pages 203-208

  Check, J H ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Follicle maturing drugs; Human chorionic gonadotropin; Luteal phase defects; Miscarriage; Progesterone therapy

Indexed keywords

ALPHA TOCOPHEROL; ANTIGESTAGEN; CHORIONIC GONADOTROPIN; ENDOMETRIN; ESTRADIOL; FOLLICLE MATURING DRUG; MIFEPRISTONE; NEW DRUG; PROGESTERONE; UNCLASSIFIED DRUG;

ABSCESS; CONGENITAL DISORDER; CORPUS LUTEUM; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; ENDOMETRIUM BIOPSY; FEMALE; FEMALE INFERTILITY; FOOD AND DRUG ADMINISTRATION; HEART DISEASE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; INJECTION SITE PAIN; LOW DRUG DOSE; LUTEAL INSUFFICIENCY; MULTIPLE CYCLE TREATMENT; MUSCLE BLEEDING; MYCOSIS; NEURAL TUBE DEFECT; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATIENT SELECTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PROGESTERONE SYNTHESIS; RECURRENT ABORTION; REVIEW; RISK REDUCTION; SPONTANEOUS ABORTION; STOMACH DISEASE; TABLET FORMULATION; VAGINA DISEASE; VERTIGO;

ABORTION, HABITUAL; ADMINISTRATION, INTRAVAGINAL; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; PREGNANCY; PROGESTERONE;

EID: 73949146444     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Csapo A.I., Pukkinen M.: "Indispensability of the human corpus luteum in the maintenance of early pregnancy: lutectomy evidence". Obstet. Gynecol. Surv., 1978, 3, 69.
2. Brogden R.N., Goa K.L., Faulds D.: "Mifepristone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential". Drugs, 1993, 45, 384.
3. Birgerson L., Odlind V.: "Early pregnancy termination with anti-progestin: a comparative clinical study of RU486 given in two dose regimens and Epostane". Fertil. Steril., 1987, 48, 565.
4. Kovacs L., Sas M., Resch B.A., Ugocasi G., Swahn M.L., Bygdeman M. et al.: "Termination of very early pregnancy by RU486 - an antiprogestational compound". Contraception, 1984, 29, 399.
5. Navot D., Laufer N., Kopolovic J., Rabinowitz R., Birkenfeld A., Lewin A. et al.: "Artificially induced cycles and establishment of pregnancies in the absence of ovaries". N. Engl. J. Med., 1986, 314, 806.
6. Noyes R.W., Hertig A.T., Rock J.: "Dating the endometrial biopsy". Fertil. Steril., 1950, 1, 3.
7. Jones G.S., Delfa E.: "Endocrine patterns in term pregnancies following abortion". JAMA, 1951, 146, 1212.
8. Andrews W.C.: "Luteal phase defects". Fertil. Steril., 1979, 32, 501.
9. Jones G.S.: "The luteal phase defect". Fertil. Steril., 1976, 27, 35.
10. Soules M.R., Wiebe R.H., Aksel S., Hammond C.B.: "The diagnosis and therapy of luteal phase deficiency". Fertil. Steril., 1977, 28, 1033.
11. Wentz A.C.: "Endometrial biopsy in the evaluation of infertility". Fertil. Steril., 1980, 33, 121.
12. Shangold M., Berkeley A., Gray J.: "Both midluteal serum progesterone levels and late luteal endometrial histology should be assessed in all infertile women". Fertil. Steril., 1983, 40, 627.
13. Murthy Y.S., Arronet G.H., Parekh M.C.: "Luteal phase inadequacy; its significance in infertility". Obstet. Gynecol., 1970, 36, 758.
14. Cooke I.D., Morgan C.A., Parry T.E.: "Correlation of endometrial biopsy and plasma progesterone levels in infertile women". J. Obstet. Gynecol. Br. Commonw, 1972, 76, 647.
15. Huang K.E.: "The primary treatment of luteal phase inadequacy: progesterone versus clomiphene citrate". Am. J. Obstet. Gynecol., 1986, 155, 824.
16. Huang K.E., Muechler E.K., Bonfiglio T.A.: "Follicular phase treatment of luteal phase defect with follicle stimulating hormone in infertile women". Obstet. Gynecol., 1984, 64, 32.
17. Jones G.S., quoted by Chez R.A.: "Proceedings of the symposium, progesterone, progestins, and fetal development". Fertil. Steril., 1978, 30, 16.
18. Jones G.S., Poumand K.: "An evaluation of etiologic factors and therapy in 555 private patients with primary infertility". Fertil. Steril., 1962, 13, 398.
19. Harlap S., Shiono P.H., Ramcharan S.: "A life table of spontaneous abortions and the effects of age, parity, and other variables". In: Porter I.H., Hook E.B. (eds.): Human Embryonic and Fetal Death. New York, Academic Press, 1980, 145.
20. Czeizel A., Bognar Z., Rockenbauer M.: "Some epidemiological data on spontaneous abortion in Hungary, 1971-1980". J. Epidemiol. Commun Health, 1984, 38, 143.
21. Check J.H., Chase J.S., Nowroozi K., Wu C.H., Adelson H.G.: "Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters". Int. J. Fertil., 1987, 32, 192.
22. Yeko T.R., Gorrill M.J., Hughes L.H., Rodi D.A., Buster J.E., Saver M.V.: "Timely diagnosis of early ectopic pregnancy using a single blood progesterone measurement". Fertil. Steril., 1987, 48, 1048.
23. Check J.H., Winke C.A., Check M.L.: "Abortion rate in progesterone treated women presenting initially with low first trimester serum progesterone levels". Am. J. Gynecol. Health, 1990, 4, 63.
24. Choe J.K., Check J.H., Nowroozi K., Benveniste R., Barnea E.R.: "Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacements in intrauterine pregnancies when serum progesterone levels are low". Gynecol. Obstet. Invest., 1992, 34, 133.
25. Szekeres-Bartho J., Faust Zs., Varga P.: "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes". Am. J. Reprod. Immunol., 1995, 34, 342.
26. Check J.H., Arwitz M., Gross J., Szekeres-Bartho J., Wu C.H.: "Evidence that the expression of progesterone induced blocking factor by maternal T-lymphocytes is positively correlated with conception". Am. J. Reprod. Immunol., 1997, 38, 6.
27. Check J.H., Ostrzenski A., Klimek R.: "Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women". Am. J. Reprod. Immunol., 1997, 37, 330.
28. Cowchock F.S., Smith J.B.: "Predictors for live birth after unexplained spontaneous abortions: correlation between immunological test results, obstetric histories, and outcome of the next pregnancy without treatment". Am. J. Obstet. Gynecol., 1992, 167, 1208.
29. Quenby S.M., Farquharson R.G.: "Predicting recurring miscarriage: What is important?". Obstet. Gynecol., 1993, 82, 132.
30. Clifford K., Rai R., Regan L.: "Future pregnancy outcome in unexplained recurrent first trimester miscarriage". Hum. Reprod., 1997, 12, 387.
31. Christiansen O.B., Pedersen B., Rosgaard A., Husth M.: "A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage". Hum. Reprod., 2002, 17, 809.
32. Check J.H., Tarquini P., Gandy P., Lauer C.: "A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters". Gynecol. Obstet. Invest., 1995, 39, 257.
33. Khan N., Richter K.S., Newsome T.L., Blaker E.J., Yankov V.I.: "Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer". Fertil. Steril., 2009, 91, 2445.
34. Check J.H., Nowroozi K., Wu C.H., Adelson H.G., Lauer C.: "Ovulation inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects". Int. J. Fertil., 1988, 33, 252.
35. Check J.H., Adelson H.G.: "The efficacy of progesterone in achieving successful pregnancy: II, in women with pure luteal phase defects". Int. J. Fertil., 1987, 32, 139.
36. Soules M.R., Wiebe R.H., Aksel S., Hammond C.B.: "The diagnosis and therapy of luteal phase deficiency". Fertil. Steril., 1977, 28, 1033.
37. Wentz A.C., Herbert C.M., Maxson W.S., Garner C.H.: "Outcome of progesterone treatment of luteal phase inadequacy". Fertil. Steril., 1984, 41, 856.
38. McAuley J.W., Kroboth F.J., Kroboth P.D.: "Oral administration of micronized progesterone: a review and more experience". Pharmacotherapy, 1996, 16, 453.
39. Licciardi F.L., Kwiatkowski A., Noyes N.L., Berkeley A.S., Krey L.L., Grifo J.A.: "Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study". Fertil. Steril., 1999, 71, 614.
40. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., Sauer M.V.: "Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study". Fertil. Steril., 1994, 62, 485.
41. Levy T., Gurevitch S., Bar-Hava I., Ashkenazi J., Magazanik A., Homburg R. et al.: "Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet". Hum. Reprod., 1999, 14, 606.
42. Ng E.H., Chan C.C., Tang O.S., Ho P.C.: "A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment". Eur. J. Obstet. Gynecol. Reprod. Biol., 2007, 131, 182.
43. Katz Z., Lancet M., Skornik J., Chemke J., Mogilner B.M., Klinberg M.: "Teratogenicity of progesterones given during the first trimester of pregnancy". Obstet. Gynecol., 1985, 65, 775.
44. Check J.H., Rankin A., Teichman M.: "The risk of fetal anomalies as a result of progesterone therapy during pregnancy". Fertil. Steril., 1986, 45, 575.
45. Check J.H., Lee G., Espstein R., Vetter B.: "Increased rate of preterm deliveries in untreated women with luteal phase deficiencies". Gynecol. Obstet. Invest., 1992, 33, 183.
46. Jones G.S., quoted by Chez R.A.: "Proceedings of the symposium, Progesterone, Progestins, and Fetal Development". Fertil. Steril., 1978, 30, 16.
47. Jones G.S., Poumand K.: "An evaluation of etiologic factors and therapy in 555 private patients with primary infertility". Fertil. Steril., 1962, 13, 398.
48. Check J.H., Chase J.S., Wu C.H., Adelson H.G., Teichman M., Rankin A.: "The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women". Int. J. Fertil., 1967, 32, 133.
49. Svigos J.: "Preliminary Experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion". Clin. Reprod. Fertil., 1982, 1, 131.
50. Harrison R.E.: "Treatment of habitual abortion with human chorionic gonadotrophin: results of open and placebo-controlled studied". Eur. J. Obstet. Gynecol. Reprod. Biol., 1985, 20, 159.
51. Harrison R.F.: "Human chorionic gonadotropin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study". Eur. J. Obstet. Gynecol. Reprod. Biol., 1992, 47, 175.
52. Quenby S., Farquharson R.G.: "Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial". Fertil. Steril., 1994, 62, 708.
53. Scott J.R., Pattison N.: "Human chorionic gonadotrophin for recurrent miscarriage". Cochrane Database Syst. Rev., 2000 (2), CD000101.
54. Witt B.R., Wolf G.C., Wainwright C.J., Johnston P.D., Thorneycroft I.H.: "Relaxin, CA-125, progesterone, estradiol, Schwangerschaft protein and human chorionic gonadotropin as predictors of outcome in threatened and nonthreatened pregnancies". Fertil. Steril., 1990, 53, 1029.
55. Oates-Whitehead R.M., Haas S.M., Carrier J.A.: "Progestegen for preventing miscarriage". Cochrane Database Syst. Rev., 2003 (4), CD003511.
56. Miyakawa I., Ikeda I., Maeyama M.: "Plasma hormone profile of threatened abortion and its prognosis". Int. J. Gynaecol. Obstet., 1977, 15, 12.
57. Hertz J.B., Larsen J.F., Suenstrup B., Johnson S.G.: "Estradiol, estradiol and human placental lactogen in serum in threatened abortion". Acta Obstet. Gynecol. Scand., 1979, 58, 365.
58. Yuen B.H., Livingston J.E., Poland B.J., Wittmann B.K., Sy L., Cannon W.: "Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy". Obstet. Gynecol., 1980, 57, 207.
59. Check J.H., Lurie D., Davies E., Vetter B.: "Comparison of first trimester serum estradiol levels in aborters versus nonaborters during maintenance of normal progesterone levels". Gynecol. Obstet. Invest., 1992, 34, 206.